Digital health coaching designed for the public sector

Prediabetes

The prevalence of pre-diabetes is increasing worldwide, and experts have projected that more than 470 million people will have pre-diabetes by 2030.

Using our evidence-based programme for patients with pre-diabetes, 65% of patients achieved reduced HbA1c levels and 40% are reverted to a non-pre-diabetic state after 6 months.

Obesity

Worldwide, 39% of adults aged 18+ are overweight and 13 % are obese. This number is rising and significantly higher in many geographies.

The increased risk of lifestyle disease is directly correlated.

The evidence-based Liva programme targeting obesity has helped more than 6000 people with weight loss, reducing the risk of lifestyle diseases sustainably. The average weight loss is 6 kg after 12 months.   

Diabetes

According to WHO, the global prevalence of diabetes among adults over 18 years is 8.5%.

The global cost of diabetes is $825 billion a year.

After 6 months on the Liva programme, 85% of patients with type 2 diabetes reduce their HbA1c levels, 35% are no longer diabetic and  the financial saving to society is vast.

Heart disease

Heart disease, also known as cardiovascular disease (CVD), is one of the leading causes of death worldwide.

The evidence-based Liva programme targeting heart disease is specifically designed to target the risk factors associated with this chronic condition.

Liva have already developed a significant portfolio of graduated patients who have minimised their risk of developing heart disease in the future, a portfolio which is growing on a daily basis.

COPD

5% of deaths worldwide are caused by COPD.

The Liva COPD programme supports people in managing their condition, alerting health professionals to engage when required and thereby keeping patients’ safe.

Liva also offers evidence-based, effective smoking cessation programmes with over 60% of patients with a goal to stop smoking reducing their number of cigarettes per day significantly.

Mental health

25% of the global population is affected by mental or neurological disorders (such as anxiety, stress or depression) at some point during their lives.

Over 200 million people currently take medication to support their management of these conditions.

The Liva Mental Health programmes are designed to help people manage these conditions through personalised support from health professionals, structured daily routine programs and expert resources.

Other conditions

The Liva programme can be used as a tool to help monitor many conditions where lifestyle support is beneficial.

The Liva programme have been successful with providing support for patients suffering with alcohol addiction, cancer, gestational diabetes.

Comorbidities

The Liva programme is specifically designed to take comorbidities of each condition into account.

41% of Liva patients have more than one condition to manage and Liva prides itself on supporting these effectively through its multi-disciplinary team of heath professionals.

Health professionals can choose from several programmes targeting specific comorbities, allowing a truly personalised programme for each and every individual.